Back to Search Start Over

Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study

Authors :
Annalisa Davin
Carol Brayne
Xin Yi Gwee
Sanmei Chen
Nicolas Cherbuin
Pierre-Marie Preux
Tze Pin Ng
Richard B. Lipton
Yuda Turana
Ji Won Han
Frank Jessen
Martin P.J. van Boxtel
Normah Che Din
Roberta Vaccaro
Mindy J. Katz
Perminder S. Sachdev
Suzana Shahar
Julian N. Trollor
Fiona E. Matthews
Qi Gao
Javier Santabárbara
Mary Ganguli
Antonio Lobo
Henry Brodaty
Alexander Pabst
Susanne Röhr
Shuzo Kumagai
Marie-Laure Ancelin
Kaarin J. Anstey
Maëlenn Guerchet
Seung Wan Suh
Erin Jacobsen
Darren M. Lipnicki
Cuiling Wang
Antonio Guaita
Sebastian Köhler
Ki Woong Kim
Karen Ritchie
Yvonne Suzy Handajani
Beth E. Snitz
Divya Vanoh
Pascal M'Belesso
Isabelle Carrière
Kenji Narazaki
Blossom C. M. Stephan
Steffi G. Riedel-Heller
Raúl López-Antón
Nicole A. Kochan
John D. Crawford
Psychiatrie & Neuropsychologie
Section Neuropsychology
RS: FPN NPPP I
RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience
Occupational Health and Public Health (ISAP)
Universität Leipzig [Leipzig]-Occupational Health and Public Health (ISAP)-Institute of Social Medicine
Trinity College Dublin
Faculty of Medicine [Cologne]
University Hospital of Cologne [Cologne]-University of Cologne
DZNE, Bonn, Germany
Faculty of Medicine [Jakarta, Indonesia]
Universitas Indonesia [Jakarta, Indonesia]
Department of Public Health and Primary Care [Cambridge, UK] (Institute of Public Health)
University of Cambridge [UK] (CAM)
MRC Biostatistics Unit [Cambridge, UK]
Institute of Health & Society [Newcastle upon Tyne, UK]
Newcastle University [Newcastle]
Institute of Health & Society
Saul B. Korey Department of Neurology
Yeshiva University- Albert Einstein College of Medicine [New York]
Neuroépidémiologie Tropicale (NET)
CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST)
Université de Limoges (UNILIM)-Université de Limoges (UNILIM)
Service de l'Information Médicale et de l'Évaluation [CHU Limoges] (SIME)
CHU Limoges
Laboratoire de Biostatistique et d'Informatique Médicale
Université de Limoges (UNILIM)
University of Edinburgh
Seoul National University [Seoul] (SNU)
Seoul National University Hospital
University Kebangsaan Malaysia
University Sains Malaysia
Partenaires INRAE
Maastricht University Medical Centre (MUMC)
Maastricht University [Maastricht]
University of Pittsburgh School of Medicine
Pennsylvania Commonwealth System of Higher Education (PCSHE)
University of Fukuoka
Röhr, Susanne [0000-0001-9385-0669]
Apollo - University of Cambridge Repository
Source :
Alzheimers research & therapy, 12(1):167. BioMed Central Ltd, Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2020), Zaguán. Repositorio Digital de la Universidad de Zaragoza, instname, Alzheimer's research & therapy 12(1), 167 (2020). doi:10.1186/s13195-020-00734-y, Alzheimer's Research & Therapy, Alzheimer's Research & Therapy, 2020, 12 (167), ⟨10.1186/s13195-020-00734-y⟩, Zaguán: Repositorio Digital de la Universidad de Zaragoza, Universidad de Zaragoza
Publication Year :
2020

Abstract

International audience; Background: Subjective cognitive decline (SCD) is recognized as a risk stage for Alzheimer's disease (AD) and other dementias, but its prevalence is not well known. We aimed to use uniform criteria to better estimate SCD prevalence across international cohorts. Methods: We combined individual participant data for 16 cohorts from 15 countries (members of the COSMIC consortium) and used qualitative and quantitative (Item Response Theory/IRT) harmonization techniques to estimate SCD prevalence. Results: The sample comprised 39,387 cognitively unimpaired individuals above age 60. The prevalence of SCD across studies was around one quarter with both qualitative harmonization/QH (23.8%, 95%CI = 23.3-24.4%) and IRT (25.6%, 95%CI = 25.1-26.1%); however, prevalence estimates varied largely between studies (QH 6.1%, 95%CI = 5.1-7.0%, to 52.7%, 95%CI = 47.4-58.0%; IRT: 7.8%, 95%CI = 6.8-8.9%, to 52.7%, 95%CI = 47.4-58.0%). Across studies, SCD prevalence was higher in men than women, in lower levels of education, in Asian and Black African people compared to White people, in lower- and middle-income countries compared to high-income countries, and in studies conducted in later decades. Conclusions: SCD is frequent in old age. Having a quarter of older individuals with SCD warrants further investigation of its significance, as a risk stage for AD and other dementias, and of ways to help individuals with SCD who seek medical advice. Moreover, a standardized instrument to measure SCD is needed to overcome the measurement variability currently dominant in the field.

Details

Language :
English
Database :
OpenAIRE
Journal :
Alzheimers research & therapy, 12(1):167. BioMed Central Ltd, Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2020), Zaguán. Repositorio Digital de la Universidad de Zaragoza, instname, Alzheimer's research & therapy 12(1), 167 (2020). doi:10.1186/s13195-020-00734-y, Alzheimer's Research & Therapy, Alzheimer's Research & Therapy, 2020, 12 (167), ⟨10.1186/s13195-020-00734-y⟩, Zaguán: Repositorio Digital de la Universidad de Zaragoza, Universidad de Zaragoza
Accession number :
edsair.doi.dedup.....17044fd6fa103b22d9f8e1bf2c2d5245
Full Text :
https://doi.org/10.1186/s13195-020-00734-y